The opioid abuse epidemic, which has affected construction along with other work environments in the U.S., may have crested, according to recently obtained data.
根据Quest Diagnostics的说法，一家领先的临床实验室，测试员工中药物使用的总体阳性率是2012年的30年低点，但从2016年到2017年没有变化。阿片类药片的测试呈阳性，从2016年到2017年显着下降。到实验室。由于工人的阿片类药物呈阳性的测试呈降低17％，因此控制鸦片过度使用和过度处方的措施正在起作用。
“We’re encouraged by this data,” says Barry Sample, senior director of science and technology for Quest Diagnostics. “We’ve had three consecutive years for decline [in use] of hydrocodone and six years decline for oxycodone,” he says. “We can’t prove there’s cause and effect, but overall it’s good news. And it helps provide a safer work environment.”
但是数据并不是一个好消息 - 滥用可乐和速度在该国某些地区正在飙升。
“我们担心在某些地理区域中，我们看到可卡因和甲基苯丙胺的使用都在增加。这是国家雇主的挑战。” Quest Diagnostics科学总监Kimberly Samano博士说。
The Centers for Disease Control recently noted the overall national opioid prescribing rate fell in 2017 to its lowest rate in a decade.
这些发现是针对过度使用止痛药的持续战争以及与障碍有关的事故，长期员工成瘾以及工作场所中其他药物滥用结果的相应问题的最新报告。最近，宾夕法尼亚州州长汤姆·沃尔夫（D）否决了州参议院第936号法案。共和党的支持者说，这项措施将有助于解决该州的阿片类药物问题，但沃尔夫声称所谓的“公式提议”将为企业和企业和企业和企业节省资金保险公司，但不会帮助对抗止痛药的滥用。
“Senate Bill 936 is not a bill designed to fight the opioid crisis. Senate Bill 936 threatens health care for millions of workers who could be injured on the job,” Wolf said in a statement. “My administration has outlined a number of executive and legislative actions that can be taken immediately to address the rising misuse and overprescribing of opioids in the health care system, including Workers’ Compensation. Implementing those actions is my top priority.”
根据药房服务IWP 2015年的风险和保险报告，“阿片类药物和受伤的工人，第二部分”，宾夕法尼亚州以外的每个州都创建了一项处方药监测计划（PDMP）。目的是防止在多家药店进行医生购物或填写相同的处方。报告指出：“当受伤的工人在药房中填写处方时，药剂师可以在PDMP内获取患者的病史，从而提供额外的安全水平，以防止阿片类药物滥用。”
Pennsylvania’s failure to enact such a workers’ compensation provision follows on the heels of a similar failure in Louisiana. One state that has succeeded in adopting such a provision is California, which passed a formulary in 2015 that went into effect on Jan. 1, 2018. New York also has been considering a formulary.
药房福利经理Mymatrixx的2017年报告指出，控制阿片类药物疼痛处方的努力进展。报告指出：“我们希望这一趋势能够继续下去。”
